Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 21INDUSTRY 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Promyelocytic, Acute 1Leukemia 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

Tretinoin 2Methotrexate 2Mercaptopurine 2Gemtuzumab 2Flow Cytometry 2sargramostim 1Topotecan 1Microscopy 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Blotting, Western 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Promyelocytic, Acute × Arsenic Trioxide × Clear all
NCT00551460 2023-01-10

S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

SWOG Cancer Research Network

Phase 2 Completed
78 enrolled 8 charts
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡